CClinicalTrials.gg
CompletedNCT02437773Updated Nov 6, 2020

Neurocircuit Mechanisms of OCD Across the Lifespan

An interventional study of Cognitive Behavioral Therapy - Adolescents and Stress Management Therapy - Adolescents in Obsessive-Compulsive Disorder, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 13 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-06.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
206
Allocation
Randomized
Ages
13 Years to 45 Years
Sex
All
01

Study summary

Obsessive-compulsive disorder (OCD), characterized by intrusive thoughts (obsessions) and related behavioral rituals (compulsions), is a common psychiatric illness that often emerges in childhood and causes life-long disability in over 50% of patients. Psychological theory suggests that OCD symptoms are driven by a person's difficulty disengaging their feelings from simple tasks (e.g. washing hands, locking a door) due to excessive anxiety about performance errors. Cognitive behavioral therapy (CBT), the gold standard treatment for OCD, repeatedly exposes patients to their OCD-stressor until this anxiety is reduced. While CBT is typically more effective in teenagers than adults, patients from both age groups are usually left with residual symptoms, highlighting the need for better treatments. In this study, CBT will be studied in both teen-aged and adult patients. Two groups, both with childhood onset OCD, will be randomized to either CBT for OCD or stress management training (SMT), an active therapy but with minimal effects on OCD symptoms. The investigators will also study age-matched, healthy controls as comparison subjects.

Before and after 12 weeks of CBT, all subjects will undergo functional Magnetic Resonance Imaging (fMRI) scans to see what regions of the brain become active when a concentration task is performed and how that activation is changed after CBT. The purpose of this study is to demonstrate the brain changes associated with CBT treatment and how differences in these changes in teenage compared to adult patients may drive differences in CBT response.

Read the detailed description

While the study itself is of parallel design for its data-collection and measurement purpose, it is listed as a partial-crossover design in the IRB-approved protocol because subjects randomized to the SMT group are given the option of entering 12-weeks of CBT sessions after all of their SMT data collection. To understand brain changes that occur with CBT compared to SMT in both age groups, the investigators will collect fMRI data before and after therapy. Some limited data will be collected in patients who are initially randomized to SMT but then opt to crossover to CBT. fMRI data will also be collected in healthy teens and adults before and after 12 weeks (but without intervening therapy) to allow the investigators to control for the simple effects of time that may cause brain changes that are not related to therapy.

02

Conditions studied

  • Obsessive-Compulsive Disorder

Keywords

  • OCD
03

In context

Obsessive-Compulsive Disorder

606 studies on the registry are indexed under Obsessive-Compulsive Disorder; 160 are open to participants now.

This study's enrollment of 206 is above the median of 45 across 492 interventional studies indexed under Obsessive-Compulsive Disorder.

Browse Obsessive-Compulsive Disorder studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for all OCD Subjects \& Healthy Volunteers:

  • Male or female
  • Age 13-17 (inclusive) subjects diagnosed with OCD, age of onset before 15 years
  • Age 25-45 (inclusive) subjects diagnosed with OCD, age of onset before 15 years
  • Age 13-17 (inclusive) year old healthy volunteers
  • Age 25-45 (inclusive) year old healthy volunteers
  • OCD adolescent and adult subjects can be on medications but will have to be on a stable medication regimen for at least 4 weeks prior to enrolling.
  • Able and willing to give informed consent
  • Ability to tolerate small, enclosed spaces without anxiety

Exclusion Criteria for OCD Subjects:

  • Anyone between the ages of 18-24 (inclusive range)
  • No lifetime diagnosis of bipolar or psychosis disorders
  • Age of OCD onset after 15 years old
  • No substance/alcohol abuse in the past 6 months
  • No lifetime history of substance/alcohol dependence
  • No evidence of suicidal intentions or behaviors in the past 6 months
  • No history of serious medical or neurological illness
  • No history of closed head injury (e.g. loss of consciousness)
  • Pregnant or trying to become pregnant

Additional Exclusion Criteria for Healthy Volunteers:

  • No history of past or current mental illness
  • Not taking any medication, prescription or non-prescription, with psychotropic effects
  • First-degree family members with OCD or tic disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
206 participants (actual)

Study arms

  • Active comparator
    Cognitive Behavioral Therapy - Adolescents

    12 Cognitive-Behavioral Therapy sessions scheduled weekly over a 12-week period.

    Behavioral: Cognitive Behavioral Therapy - Adolescents

  • Other
    Stress Management Therapy - Adolescents

    12 SMT sessions scheduled weekly over a 12-week period. After study completion, the OCD subjects who received SMT may derive benefit for non-OCD anxiety symptoms. They will be offered a 12-week course of CBT with a study therapist to directly target OCD symptoms (i.e., a partial cross-over).

    Behavioral: Stress Management Therapy - Adolescents · Behavioral: Optional CBT - Adolescents

  • Active comparator
    Cognitive Behavioral Therapy - Adults

    12 CBT sessions scheduled weekly over a 12-week period.

    Behavioral: Cognitive Behavioral Therapy - Adults

  • Other
    Stress Management Therapy - Adults

    12 SMT sessions scheduled weekly over a 12-week period. After study completion, the OCD subjects who received SMT may derive benefit for non-OCD anxiety symptoms. They will be offered a 12-week course of CBT with a study therapist to directly target OCD symptoms (i.e., a partial cross-over).

    Behavioral: Stress Management Therapy - Adults · Behavioral: Optional CBT - Adults

  • Other
    Healthy Control - Adolescents

    Healthy control adolescents matched to gender, race and socioeconomic status (SES) with adolescent patients with OCD will be enrolled. These healthy adolescents will be scanned with fMRI before and after 12 weeks, but without any intervention (i.e., no therapy).

    Other: fMRI only - Healthy Control Adolescents

  • Other
    Healthy Control - Adults

    Healthy control adults matched to gender, race and socioeconomic status (SES) with adult patients with OCD will be enrolled. These healthy adults will be scanned with fMRI before and after 12 weeks, but without any intervention (i.e., no therapy).

    Other: fMRI only - Healthy Control Adults

  • Other
    Optional CBT - Adolescents

    OCD adolescent participants who were randomized to the SMT and have completed all study procedures will be offered an additional 12 weeks of Optional Cognitive-Behavioral Therapy.

    Behavioral: Optional CBT - Adolescents

  • Other
    Optional CBT - Adults

    OCD adult participants who were randomized to the SMT and have completed all study procedures will be offered an additional 12 weeks of Optional Cognitive-Behavioral Therapy.

    Behavioral: Optional CBT - Adults

Interventions

  • BehavioralCognitive Behavioral Therapy - Adolescents

    A therapy which gradually yet repeatedly exposes adolescent patients to their obsessive compulsive-relevant "error" cues during a task performance until their anxiety habituates.

    Also known as: CBT

  • BehavioralStress Management Therapy - Adolescents

    An active control therapy with minimal effects on OCD symptoms.

    Also known as: SMT

  • BehavioralOptional CBT - Adolescents

    This is the cross-over element for those that completed the SMT treatment group and opt to have the OCD treatment.

    Also known as: CBT

  • BehavioralCognitive Behavioral Therapy - Adults

    A therapy which gradually yet repeatedly exposes adult patients to their obsessive compulsive-relevant "error" cues during a task performance until their anxiety habituates.

    Also known as: CBT

  • BehavioralStress Management Therapy - Adults

    An active control therapy with minimal effects on OCD symptoms.

    Also known as: SMT

  • BehavioralOptional CBT - Adults

    This is the cross-over element for those that completed the SMT treatment group and opt to have the OCD treatment.

    Also known as: CBT

  • OtherfMRI only - Healthy Control Adults

    Two fMRI's only, scheduled at 12-weeks apart. This is for Healthy Control Adults and is used only as a means for observation, NOT as an intervention to be studied.

  • OtherfMRI only - Healthy Control Adolescents

    Two fMRI's only, scheduled at 12-weeks apart. This is for Healthy Control Adolescents and is used only as a means for observation, NOT as an intervention to be studied.

06

What researchers measure

Primary outcomes

  1. Brain activity as assessed by Magnetic Resonance Imaging (fMRI) scans

    fMRI BOLD signal response of posterior medial frontal cortex (pMFC), ventral medial prefrontal cortex (vmPFC) and anterior insula (aIns) during performance monitoring. This signal will be measured as BOLD contrast estimates for errors compared to correct trials based on average signal in a priori defined regions of interest for pMFC, vmPFC and aIns. The investigators are looking for increases in pMFC activation in adolescents from pre- to post-treatment. In contrast, the investigators are looking for increases in inverse connectivity (resting state and during task) between vmPFC and aIns in adults from pre- to post-treatment.

    Time frame: Baseline to 12-weeks

Secondary outcomes

  1. OCD symptom severity measured by the Yale Brown Obsessive Compulsive Scale for adults or the Child Yale Brown Obsessive Compulsive Scale for adolescents.

    OCD symptom severity measured by the Yale Brown Obsessive Compulsive Scale for adults and the Child Yale Brown Obsessive Compulsive Scale for adolescents. This scale is administered by an independent assessor to rate OCD symptom severity on a scale of 0 to 40, with 40 being most severe. The investigators are looking for decreases in OCD severity ratings from pre- to post-treatment.

    Time frame: Baseline to 12-weeks

07

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
08

References and documents

Publications

  • Rueppel M, Mannella KA, Fitzgerald KD, Schroder HS. Post-error slowing in anxiety and obsessive-compulsive disorders. Cogn Affect Behav Neurosci. 2022 Jun;22(3):610-624. doi: 10.3758/s13415-021-00976-9. Epub 2021 Dec 29. PubMed 34966981 ↗
  • Norman LJ, Mannella KA, Yang H, Angstadt M, Abelson JL, Himle JA, Fitzgerald KD, Taylor SF. Treatment-Specific Associations Between Brain Activation and Symptom Reduction in OCD Following CBT: A Randomized fMRI Trial. Am J Psychiatry. 2021 Jan 1;178(1):39-47. doi: 10.1176/appi.ajp.2020.19080886. Epub 2020 Aug 28. PubMed 32854533 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02437773
Lead sponsor
University of Michigan
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Kate D. Fitzgerald (Associate Professor, Department of Psychiatry, University of Michigan, University of Michigan) — Principal investigator
First posted
May 8, 2015
Start date
Mar 9, 2015
Primary completion
Apr 13, 2020
Completion
Oct 21, 2020
Last update
Nov 6, 2020

Study contacts

Kate Fitzgerald, MD
principal investigator · University of Michigan, Dept of Psychiatry

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion